A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation
Robert Brian Jenkins, Yuanyuan Xiao, Hugues Sicotte et al. · Nature Genetics · 2012
Cited by 140 works. doi:10.1038/ng.2388 Open-access PDF
Authors
- Robert Brian Jenkins
- Yuanyuan Xiao
- Hugues Sicotte
- Paul A. Decker
- Thomas M. Kollmeyer
- Helen M. Hansen
- Matthew Kosel
- Shichun Zheng
- Kyle M. Walsh
- Terri Rice
- Paige M. Bracci
- Lucie S. Mccoy
- Ivan V. Smirnov
- Joseph S. Patoka
- George Hsuang
- Joe L. Wiemels
- Tarık Tihan
- Alexander R. Pico
- Michael D. Prados
- Susan Marina Chang
References
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses
- IDH1 and IDH2 Mutations in Gliomas
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
- A Unified Approach to Genotype Imputation and Haplotype-Phase Inference for Large Data Sets of Trios and Unrelated Individuals
- Genotype Imputation
- Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed Oligoastrocytomas
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
- IDH mutation impairs histone demethylation and results in a block to cell differentiation
- Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402